authors
- Leighl, NB
- Laurie, SA
- Knox, JJ
- Ellis, Peter
- Shepherd, FA
- Burkes, RL
- Vincent, M
- Pond, Gregory
- Zwiebel, JA
- Moore, MJ
Phase I/II study of GTI-2040 plus docetaxel as 2nd-line treatment in non-small cell lung cancer (NSCLC) and other solid tumors.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- June 1, 2005
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal